Our structure
Executive Board
Florence Baron-Papillon
President (Sanofi)
Juan Carlos Jaramillo
Vice-President & Treasurer (Valneva)
Andreas Potthoff
(Abbott)
Lorenzo Wittum
(AstraZeneca)
Basil Babychan
(Bilthoven Biologicals)
Sharon McHale
(CSL Seqirus)
Guillermo De Juan Echávarri
(GSK)
Lydia Ogden
(Johnson & Johnson)
Alexander Meier
(Moderna)
Nicoletta Luppi
(MSD)
Kelly Cappio
(Novavax)
Tobias Cousens
(Pfizer)
Executive Office
Sibila Quilici
Executive Director
Laurent Louette
Director Public Affairs & Country Liaison
Anna Czwarno
Director, Regulatory and R&D
Charlotte Vernhes
Director, Scientific and Medical Affairs
Anna Vicere
Associate Director, Public Affairs & Access Policy
Ingrid Weindorfer
Project Manager
Kateryna Khmilevska
Junior Science and Regulatory Manager
Polina Zoteva
Communications Lead
Anne Meynaerts
Assistant Manager
Eva Antunano
Assistant Manager
Working Group Chairs
Public Affairs
Nilsy Desaint
MSD
Regulatory Affairs
Pascale Vintezou
Sanofi
RESEARCH, INNOVATION & MEDICAL
Jean Lang
Sanofi
Market Access
Kathleen Grieve
MSD
Manufacturing & Supply
Niko Salo
Pfizer
NATIONAL VACCINE INDUSTRY GROUP’S TASK FORCE
Gisela Payeras Bailly
GSK